On Tuesday, JPMorgan made a significant adjustment to its view on Raymond James Financial Inc . (NYSE:), downgrading the firm’s stock rating from Overweight to Neutral. Despite the downgrade, the financial services company’s price target experienced an uplift to $166.00, marking an increase from the previous target of $151.00. According to InvestingPro analysis, RJF appears undervalued at current levels, with the stock trading at an attractive P/E ratio of 13.7x.
The shift in rating by JPMorgan reflects a nuanced stance towards Raymond (NS:) James. According to JPMorgan, Raymond James stands as a prominent beneficiary of the ongoing growth trends powering the wealth management sector, evidenced by its impressive 11.2% revenue growth over the last twelve months.
The company has successfully established a comprehensive service platform tailored to support independent financial advisors across various affiliation models, maintaining a strong financial health score of “GREAT” according to InvestingPro metrics.
JPMorgan acknowledges the enduring trends bolstering independent financial advice. However, the decision to move to a Neutral rating is influenced by the belief that the market’s expectations for a revival in investment banking may be overly optimistic. At this point, JPMorgan expresses a preference for other entities within their coverage area over Raymond James.
The revised price target of $166.00, despite the rating downgrade, suggests JPMorgan’s recognition of Raymond James’ underlying value and potential in the wealth management industry. The adjustment indicates an expectation of solid performance, albeit with a more cautious outlook on the company’s investment banking prospects relative to the broader market.
Raymond James Financial Inc. is known for providing a range of financial services to individuals, corporations, and municipalities. The company’s commitment to serving independent financial advisors through its full-service wealth platform has been a cornerstone of its business strategy. This approach has yielded strong results, with the stock delivering a 44.7% return over the past year.
InvestingPro subscribers can access 8 additional key insights and a comprehensive Pro Research Report, which provides deep-dive analysis of RJF’s performance and prospects.
In other recent news, Raymond James Financial has been the focus of several analyst adjustments following its robust earnings results. Goldman Sachs upgraded the company’s stock from Neutral to Buy, setting a new price target of $185. This optimism is based on anticipated gains to Raymond James’ fiscal year 2025-2027 earnings per share (EPS) estimates.
Raymond James reported record fourth-quarter revenues of $3.46 billion, primarily driven by a surge in advisory revenue. The company also announced an 11.1% increase in its quarterly dividend and a new share repurchase program. TD Cowen, BofA Securities, and Citi adjusted their price targets following these results, with TD Cowen maintaining a Hold rating, BofA reiterating a Buy rating, and Citi maintaining a Neutral rating.
Moreover, Raymond James anticipates an additional $5 billion in outflows in the first quarter due to the offboarding of an Office of Supervisory Jurisdiction. Despite this, BofA projects a 5-7% growth rate for net new assets in the following year. Looking ahead, Raymond James maintains a positive outlook for fiscal 2025, anticipating growth driven by increases in assets and fee-based accounts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.